When the Medication Helps but You Feel Flat

Emotional Blunting on Antidepressants: What the Research Actually Shows, Why Feeling Fades, and How Women Are Finding Their Way Back Into Sensation

TL;DR

• Feeling «flat» on an antidepressant has a name — emotional blunting — and it is common. In a 2017 survey of 669 treated patients, 46% reported it.

• Research suggests the medication may dampen reward learning: a 2023 Cambridge trial found reduced reinforcement sensitivity after three weeks on escitalopram. The relief comes with less pull toward pleasure.

• It is not always the drug. Blunting also behaves like a leftover symptom of depression itself — which is exactly why this is a conversation for your prescriber, not a reason to stop or change a dose on your own.

• Perukua — the Australian singer and facilitator who has led women’s practices in 63 countries — is not a doctor and does not speak about medication. She speaks about what happens when a woman lives only in her head: «We are only thoughts. We feel nothing.»

• While you and your doctor work on the medical side, body-first practices are a low-risk companion. A 2019 randomized trial found interoceptive-awareness training, added alongside standard care, improved emotion regulation and lowered depression in women.

What the Research Actually Shows

It is a strange complaint to bring to a doctor. The crying has stopped. The 3 a.m. dread has loosened its grip. By every measure on the questionnaire, you are better. And yet your granddaughter’s first steps land somewhere behind glass, and you cannot remember the last time a piece of music moved you. You are not sad anymore. You are not much of anything.

This has a name, and it is not rare. In a 2017 survey published in the Journal of Affective Disorders, Guy Goodwin and colleagues at Oxford questioned 669 patients being treated for depression, alongside 150 recovered controls. Forty-six percent of those currently on treatment reported emotional blunting — a narrowed range of feeling, a muted response to things that should register. Later reviews put the range across SSRIs and SNRIs somewhere between 40 and 60 percent. Whatever the precise figure, roughly half the women in any waiting room know this feeling, and most of them have never been told it has a name.

In 2023, researchers at the University of Cambridge offered a mechanism. Writing in Neuropsychopharmacology, Christelle Langley and colleagues gave 66 healthy volunteers either escitalopram or a placebo for at least three weeks, then ran them through a battery of cognitive tests. Memory and attention were untouched. But the escitalopram group showed reduced reinforcement sensitivity — they were measurably less responsive to reward, less inclined to learn from what felt good. As the study’s senior author, Professor Barbara Sahakian, put it: the drugs take away some of the emotional pain, and it seems they also take away some of the enjoyment.

Here is the part that deserves equal weight. The Oxford survey found that blunting scores tracked with self-reported depression — meaning the flatness behaves partly like a residual symptom of the illness, not purely a side effect of the pill. That single finding should stop anyone from drawing a fast conclusion. You cannot tell, from the inside, whether the numbness is the medication, the depression that has not fully lifted, or both. Only your prescriber can work that out with you — by looking at dose, at timing, at which molecule you are on, at what else is happening in your body at 52. Do not adjust or stop anything on your own. Withdrawal effects are real, relapse is real, and this is precisely the kind of question doctors are for.

What Perukua Says About Losing Touch With Feeling

Perukua is an Australian singer and facilitator who has led women’s voice and body practices in 63 countries over more than two decades. She is not a physician, she does not work with medication, and nothing she teaches is a treatment for depression. But she has spent those years watching a particular thing happen to women — the slow migration of a whole life up into the head — and she describes it with a bluntness that clinical language rarely permits.

“Usually, when we are in stress and anxiety, we lose the sensitivity of the body. We are only thoughts. We feel nothing. But the loops of thought swarm in our head.”

— Perukua

She is speaking about stress, not about SSRIs. But women on antidepressants recognise the description immediately, because the destination is the same even when the road there is different: a mind that will not stop narrating, and a body that has gone quiet underneath it.

Her instruction for that state is disarmingly plain. Perukua reports that the way back has two movements, in this order: «The first step is always awareness of what is happening. The second is slowing down.» Not analysis. Not insight. Awareness, then a deliberate drop in speed — and then, she says, the body has to be given something small and physical to report back on. A curled toe. A pulse in a fingertip. Something the mind cannot argue with.

Why the Body Is the Missing Half of This Conversation

There is a reason that instruction is not merely poetic. Emotions are not generated purely in the head; a large part of what we call feeling is the brain reading the body — heartbeat, breath, gut, muscle, temperature — and interpreting that report as joy, dread, tenderness, or nothing at all. The technical name for this signal is interoception. When attention lives entirely in thought, the signal is still being sent; it is simply not being received.

That gives you two separate dials, and they are turned by different hands. One is pharmacological: how strongly reward registers in the brain. That dial belongs to you and your doctor. The other is attentional: how much of your body’s signal you are actually picking up. That one is trainable, and it is not the doctor’s to turn.

The evidence for training it is better than most people assume. In a 2019 randomized controlled trial published in Drug and Alcohol Dependence, Cynthia Price and colleagues at the University of Washington taught interoceptive awareness — a structured, body-oriented attention practice — to women already in treatment, following 187 participants over a year. Added alongside standard care, the training improved emotion regulation and reduced depression compared with treatment as usual. The operative word in that sentence is alongside. Nobody in that study traded their care for a breathing exercise, and neither should you.

Ten Minutes Back Into Sensation

This is Perukua’s sequence, and it asks nothing of you but ten minutes and a chair. It is not a treatment and it will not replace anything you are taking. Think of it as turning up the volume on a signal that is already being broadcast.

First, breathe low, for five minutes. Rest one palm on your lower belly. Breathe so that the palm is pushed outward on the inhale — not the chest, not the shoulders, the belly. Let the exhale be longer than the inhale and unhurried. Perukua describes this slow, diaphragmatic breathing as the beginning of every exit from stress; a lengthened out-breath is also the most reliable way we know of nudging the nervous system toward calm.

Second, wake the feet. Curl your toes as if picking something up off the ground — Perukua’s image is a monkey gripping — then release. Ten slow repetitions. Feel the arch, the floor, the fabric of your sock.

Third, find your pulse. Bring thumb and index finger together into a soft ring and press very lightly. Give the whole of your attention to that contact point: the pressure, the warmth, the tingle, the beat if you can find it. Stay for two minutes. When your mind slides back into commentary — it will — return to the fingertips without scolding yourself. This is the whole exercise. Attention leaves, attention comes back.

Fourth, add a sound. On one long out-breath, let a low, quiet hum sit in your chest. Rest a hand on your sternum and find the vibration under it. Five or six hums is plenty. You are not singing; you are giving the body something unmistakable to feel.

Fifth, name one thing. Before you get up, say out loud one sensation you actually noticed — warmth in the left hand, the hum in the breastbone, the floor under the heel. One. Naming it is what closes the circuit between the body that felt it and the mind that has been living without it.

Do this daily for two weeks and keep a one-line note each evening. Then bring the notes to your doctor. What you are building is not a cure; it is data — and a more precise account of your own flatness than «I feel nothing», which is the sentence most likely to end an appointment early.

Frequently Asked Questions

FREQUENTLY ASKED QUESTIONS

Do antidepressants make you feel flat?

For a substantial minority — and possibly a majority — yes. A 2017 survey of 669 treated patients found 46% reporting emotional blunting, and reviews place the range across SSRIs and SNRIs at roughly 40–60%. A 2023 Cambridge trial suggests one reason: reduced sensitivity to reward. It is a recognised phenomenon, not something you are imagining or exaggerating.

Will SSRI emotional blunting go away?

For some women it eases as the body adjusts; for others it persists, and it is one of the more common reasons people stop their medication. Because it can respond to a change in dose or a switch to a different molecule, it is worth raising explicitly — but those are decisions for your prescriber. Stopping or tapering on your own carries real risks, including withdrawal effects and relapse.

Is it the antidepressant, or is it still the depression?

Often it is impossible to tell from the inside, and the research says so plainly: in the Oxford survey, blunting scores tracked with self-reported depression, meaning it behaves partly like a residual symptom of the illness rather than purely a side effect. Untangling the two is exactly what your doctor is trained to do — bring them specifics, not a verdict.

What can I do about emotional blunting while staying on my medication?

Keep the medical conversation going with your prescriber, and in parallel work on the attentional half of the problem. Interoceptive-awareness training — deliberately noticing breath, pulse, warmth, vibration — improved emotion regulation and reduced depression in a 2019 randomized trial when added alongside standard care. It is low-risk, it is free, and it takes ten minutes. It is a companion to treatment, never a substitute for it.

In Closing

There is a particular loneliness in getting better and feeling worse about it — in being told the treatment is working while the colour drains out of the ordinary day. Half the women on these medications know it, and almost none of them say it out loud, because it sounds ungrateful.

It is not ungrateful. It is information, and it belongs in your doctor’s office. Say the words emotional blunting; they are recognised, they are in the literature, and they will be understood. Then, while that conversation runs its course, give the other half of yourself something to do. Put a palm on your belly. Curl your toes. Hum once and feel your sternum answer. The body has been sending its report all along, faithfully, into a room where nobody was listening. Sometimes the way back into feeling begins with a fingertip.

References & Quote Sources

1

Goodwin, G.M., Price, J., De Bodinat, C., Laredo, J. «Emotional blunting with antidepressant treatments: A survey among depressed patients.» Journal of Affective Disorders, 2017; 221:31–35. (669 treated patients and 150 recovered controls; 46% of those on treatment reported emotional blunting, with blunting scores correlating with self-reported depression.)

2

Langley, C., Armand, S., Luo, Q., et al. «Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study.» Neuropsychopharmacology, 2023. (66 volunteers, at least 21 days of escitalopram or placebo; reduced reinforcement sensitivity with no impairment of «cold» cognition.)

3

Ma, H., Cai, M., Wang, H. «Emotional Blunting in Patients With Major Depressive Disorder: A Brief Non-systematic Review of Current Research.» Frontiers in Psychiatry, 2021; 12:792960. (Reviews prevalence estimates of roughly 40–60% among patients treated with SSRIs or SNRIs, and proposed serotonergic–dopaminergic mechanisms.)

4

Price, C.J., Thompson, E.A., Crowell, S., Pike, K. «Longitudinal effects of interoceptive awareness training through mindful awareness in body-oriented therapy (MABT) as an adjunct to women’s substance use disorder treatment: A randomized controlled trial.» Drug and Alcohol Dependence, 2019; 198:140–149. (N=187 women; interoceptive-awareness training added to standard care improved emotion regulation and reduced depression.)

5

Perukua, quotations translated from a published Russian-language article on anxiety and stress. Perukua is a singer and facilitator, not a physician; her statements describe her own practice and experience and are not medical advice.

6

Perukua — biography, courses and music: peruquois.com

Do you have any questions? Contact me now

Should you have any questions, please contact me via messengers below. I'll reply you shortly.